[18F]AlF-NOTA-IMB

N/A

Report date: 2025/11/20 16:04:29

NME

Base Information

Drug Name[18F]AlF-NOTA-IMB

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionProgrammed death-ligand 1 binders

TargetsProgrammed death-ligand 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesJiangsu Institute Of Nuclear Medicine

China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Institute Of Nuclear Medicine

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A